Efnisyfirlit

• Cover image
• Title page
• Copyright
• Dedication
• Dedication to William O. Foye
• Preface
• Acknowledgments
• Contributors
• Clinical Contributors
• Clinical Advisory Panel
• Contents
• Part I  Principles
• CHAPTER 1  Introduction to Medicinal Chemistry
• CHAPTER 2  Foundational Principles and Functional Group Impact on Activity
• CHAPTER 3  Drug Metabolism
• CHAPTER 4  Membrane Drug Transporters
• CHAPTER 5  Principles of Biotechnology-Derived Drugs
• Part II  Receptor Targets
• CHAPTER 6  G Protein–Coupled Receptors
• CHAPTER 7  Nuclear Receptors
• CHAPTER 8  Ion Channel Receptors
• CHAPTER 9  Enzyme/Catalytic Receptors
• Part III  Pharmacodynamic Agents
• Section 1 Drugs Impacting the Central Nervous System
• CHAPTER 10  Drugs Used to Treat Neuromuscular Disorders
• CHAPTER 11  Drugs Used to Treat Mental, Behavioral, and Cognitive Disorders
• CHAPTER 12  Drugs Used to Induce/Support Sedation or Anesthesia
• CHAPTER 13  Drugs Used to Treat Seizure Disorders
• Section 2 Drugs Impacting Pain Perception
• CHAPTER 14  Drugs Used to Treat Pain: Centrally Acting Agents
• CHAPTER 15  Drugs Used to Treat Pain: Peripherally Acting Agents
• Section 3 Drugs Impacting the Cardiovascular System
• CHAPTER 16  Drugs Used to Treat Cardiac Disorders
• CHAPTER 17  Drugs Used to Treat Hypertensive/Hypotensive Disorders
• CHAPTER 18  Drugs Used to Treat Coagulation Disorders
• CHAPTER 19  Drugs Used to Treat Dyslipidemic Disorders
• Section 4 Drugs Impacting Hormonal Systems
• CHAPTER 20  Drugs Used to Treat Diabetic Disorders
• CHAPTER 21  Drugs Used to Treat Inflammatory and Corticosteroid Deficiency Disorders
• CHAPTER 22  Drugs Used to Treat Thyroid Disorders
• CHAPTER 23  Drugs Used to Treat Calcium-Dependent Disorders
• CHAPTER 24  Drugs Used to Advance Men’s and Women’s Health
• Section 5 Drugs Impacting Immune, Gastrointestinal and Genitourinary Systems
• CHAPTER 25  Drugs Used to Treat Allergic Disorders
• CHAPTER 26  Drugs Used to Treat Gastrointestinal and Genitourinary Disorders
• Section 6 Drugs Impacting Ocular, Nasal and Pulmonary Systems
• CHAPTER 27  Drugs Used to Treat Ocular and Nasal Congestion Disorders
• CHAPTER 28  Drugs Used to Treat Pulmonary Disorders
• Section 7 Drugs Impacting Infectious and Neoplastic Disease Processes
• CHAPTER 29  Drugs Used to Treat Bacterial Infections
• CHAPTER 30  Drugs Used to Treat Viral Infections
• CHAPTER 31  Drugs Used to Treat Fungal Infections
• CHAPTER 32  Drugs Used to Treat Parasitic Infections
• CHAPTER 33  Drugs Used to Treat Neoplastic Diseases
• Section 8 Therapeutic Biologics
• CHAPTER 34  Biologics Used in the Treatment of Disease
• Part IV  Disease State Management
• CHAPTER 35  Coronary Artery Disease
• CHAPTER 36  Rheumatoid Arthritis
• CHAPTER 37  Nutrition and Obesity
• Appendix A  cLogP and cLogDpH 7.4 Values of Selected Drugs
• Appendix B  Predicted pKa Values of Commonly Prescribed Drugs
• Appendix C  pH Values of Biological Fluids
• Subject Index
• Drug Index